Data as of Apr 17
| -0.45 / -4.25%|
The 9 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 35.00 and a low estimate of 10.00. The median estimate represents a +67.49% increase from the last price of 10.15.
The current consensus among 11 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.